| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/20/2006 | WO2006076124A2 Stable, non-crystalline formulation comprising olanzapine |
| 07/20/2006 | WO2006076100A2 Tubulin isotype screening in cancer therapy using halichondrin b analogs |
| 07/20/2006 | WO2006076097A2 Stable non-crystalline formulation comprising losartan |
| 07/20/2006 | WO2006076033A1 Production and use of a gaseous vapor disinfectant |
| 07/20/2006 | WO2006076019A1 Treatment of behavioral disorders |
| 07/20/2006 | WO2006076009A2 Transcription factor modulating compounds and methods of use thereof |
| 07/20/2006 | WO2006075993A2 Nucleoside derivatives for treating hepatitis c virus infection |
| 07/20/2006 | WO2006075976A1 Application of a local anaesthetic for correcting a human eating behaviour and method for the use thereof |
| 07/20/2006 | WO2006075955A1 Pyrazolyl acylsulfonamide derivatives as endothelin converting enzyme inhibitors and useful in the treatment of chronic obstructive pulmonary disease |
| 07/20/2006 | WO2006075925A2 Method for preparation of 10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide |
| 07/20/2006 | WO2006075924A1 Antineoplastic preparation and the use of antineoplastic preparation |
| 07/20/2006 | WO2006075854A1 Composition for stimulating growth of dermal papilla cells and promoting hair follicle growth comprising vitamin c derivatives |
| 07/20/2006 | WO2006075808A1 Pharmaceutical composition comprising a p25/cdk5 inhibitor for preventing or treating a neurodegenerative disease |
| 07/20/2006 | WO2006075776A1 Therapeutic agent for chronic obstructive pulmonary disease (copd), cystic fibrosis or pulmonary hypertension |
| 07/20/2006 | WO2006075748A1 Therapeutic agent for allergic conjunctival disease |
| 07/20/2006 | WO2006075690A1 Stable medicinal composition |
| 07/20/2006 | WO2006075678A1 Photosensitive compound |
| 07/20/2006 | WO2006075642A1 Hypoxia response enhancing agent |
| 07/20/2006 | WO2006075638A1 Novel heteroaryl derivative |
| 07/20/2006 | WO2006075619A1 2-(cyclic aminocarbonyl)indoline derivative and medicinal composition containing the same |
| 07/20/2006 | WO2006075580A1 Antibacterial substances injuring bacterial cell membarane and methods of using the same |
| 07/20/2006 | WO2006075523A1 Blood cholesterol reducing oral composition |
| 07/20/2006 | WO2006075502A1 Solid preparation comprising reduced coenzyme q10 and process for production of the same |
| 07/20/2006 | WO2006075395A1 β-LACTAM ANTIBIOTIC ACTIVITY ENHANCER AND PROCESS FOR PRODUCING THE SAME |
| 07/20/2006 | WO2006075226A1 11c-labeled benzyl-lactam compounds and their use as imaging agents |
| 07/20/2006 | WO2006075165A1 Combination of oncolytic viruses with angiogenesis inhibitors |
| 07/20/2006 | WO2006075159A1 Anti-bacterial compounds |
| 07/20/2006 | WO2006075152A1 4- (1h-indol-3-yl) -pyrimidin-2-ylamine derivates and their use in therapy |
| 07/20/2006 | WO2006075095A2 Use of purine derivatives as hsp90 protein inhibitors and for treatment of cancer |
| 07/20/2006 | WO2006075094A2 Purine derivatives compositions containing the same and use thereof against cancer |
| 07/20/2006 | WO2006075084A2 Genes involved in the regulation of angiogenesis, pharmaceutical preparations containing them and uses thereof |
| 07/20/2006 | WO2006075023A2 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors |
| 07/20/2006 | WO2006075020A2 Ampa antagonist for the treatment of dizziness, including vertigo and meniere's disorder |
| 07/20/2006 | WO2006075011A2 Glycine reuptake inhibitors for treating drug and alcohol dependence |
| 07/20/2006 | WO2006075004A2 3, 8 - substituted 8-aza-bicyclo[3.2.1] octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 07/20/2006 | WO2006074991A1 Novel 2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels |
| 07/20/2006 | WO2006074985A1 5-membered annelated heterocyclic pyrimidines as kinase inhibitors |
| 07/20/2006 | WO2006074984A1 Pyrazolopyrimidines as cell cycle kinase inhibitors |
| 07/20/2006 | WO2006074957A1 Substituted aminomethylene sulphonamides, production and use thereof as medicaments |
| 07/20/2006 | WO2006074952A1 Process for preparing lansoprazole |
| 07/20/2006 | WO2006074940A2 Macrocyclic compounds and compositions useful as bace inhibitors |
| 07/20/2006 | WO2006074928A2 Topical product for preventing and treating nappy rash |
| 07/20/2006 | WO2006074925A1 Purine derivatives acting as a2a receptor agonists |
| 07/20/2006 | WO2006074924A1 3,4,(5)-substituted tetrahvdropyridines |
| 07/20/2006 | WO2006074919A2 3-AMINO-6-ARYL(OR 6-HETEROARYL)-THIENO[2,3-B]PYRIDIN-2-CARBOXAMIDES, PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME AND THEIR USE AS TNFα INHIBITORS |
| 07/20/2006 | WO2006074918A1 Agents containing folic acid, vitamin b6 and vitamin b12, and the use thereof |
| 07/20/2006 | WO2006074914A2 Human rna helicase and therapeutic uses thereof |
| 07/20/2006 | WO2006074897A1 Cinnamate salts of a beta-2 adrenergic agonist |
| 07/20/2006 | WO2006074884A1 Thiazole-4-carboxamide derivatives as mglur5 antagonists |
| 07/20/2006 | WO2006074872A1 Intravenous formulations of pde-5 inhibitors |
| 07/20/2006 | WO2006074813A1 Substituted 4-phenyltetrahydroisoquinolines, methods for producing them, their use as drug, and drug containing them |
| 07/20/2006 | WO2006074799A2 5-pyrrolidinylsulfonyl isatin derivatives |
| 07/20/2006 | WO2006074797A1 6-phenylhex-5-enoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof |
| 07/20/2006 | WO2006074789A1 1h-indole-3-carboxylic acid derivatives and their use as ppar agonists |
| 07/20/2006 | WO2006074752A1 Sachets comprising plant sterol |
| 07/20/2006 | WO2006074546A1 Lipid encapsulated interfering rna |
| 07/20/2006 | WO2006074526A1 Method and composition for treatment of neoplasms |
| 07/20/2006 | WO2006074501A1 Peptidic compounds |
| 07/20/2006 | WO2006074495A1 Substance mixture |
| 07/20/2006 | WO2006065280A3 Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods |
| 07/20/2006 | WO2006063109A9 Room-temperature stable dronabinol formulations |
| 07/20/2006 | WO2006060762A3 Pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 07/20/2006 | WO2006060419A9 Biomarkers for pre-selection of patients for anti-igf1r therapy |
| 07/20/2006 | WO2006060318A3 Quinolines and quinazoline analogs and their use as medicaments for treating cancer |
| 07/20/2006 | WO2006060084A3 Coadministration of tigecycline and digoxin |
| 07/20/2006 | WO2006059234A3 Bicyclic amides as kinase inhibitors |
| 07/20/2006 | WO2006059210A3 Fused bicyclic pyrrols as hmg-coa reductase inhibitors |
| 07/20/2006 | WO2006056877A3 Diazepine oxazolidinones as antibacterial agents |
| 07/20/2006 | WO2006055142A3 Taste-masked multiparticulate pharmaceutical compositions comprising a drug-containing core particle and a solvent-coacervated membrane |
| 07/20/2006 | WO2006054162A8 Azabicyclic muscarinic receptor antagonists |
| 07/20/2006 | WO2006054110A3 Immunotherapeutic agent |
| 07/20/2006 | WO2006054057A3 New use for cannabinoid |
| 07/20/2006 | WO2006052850A8 Motexafin lutetium phototherapy with low fluences for treating vascular inflammation |
| 07/20/2006 | WO2006052546A3 Pyrazolylmethyl heteroaryl derivatives |
| 07/20/2006 | WO2006050327A3 Lyophilized liposome formulations and method |
| 07/20/2006 | WO2006047756A3 Substituted tetracycline compounds |
| 07/20/2006 | WO2006045476A3 Gpr17 modulators, method of screening and uses thereof |
| 07/20/2006 | WO2006044687A3 Kinase inhibitors |
| 07/20/2006 | WO2006044531A3 Antisense modulation of ptp1b expression |
| 07/20/2006 | WO2006044174A9 Aryl substituted 8-azabicyclo[3.2.1]octane compounds as ligands of the melanin concentrating hormone receptor |
| 07/20/2006 | WO2006043966A3 Methods for inducing apoptosis in adipocytes |
| 07/20/2006 | WO2006042858A3 Complex comprising an antibiotic, a cyclodextrin and an interaction agent |
| 07/20/2006 | WO2006039441A3 Amorphous atorvastatin calcium |
| 07/20/2006 | WO2006039263A3 NOVEL BICYCLIC 9a-AZALIDE DERIVATIVES |
| 07/20/2006 | WO2006039252A3 Compositions and methods for treating ophthalmic diseases |
| 07/20/2006 | WO2006039231A3 Topical formulations for the treatment of depression with s adenosyl methionine |
| 07/20/2006 | WO2006038226B1 Process for making a highly compressible controlled delivery compositions of metformin |
| 07/20/2006 | WO2006037032A3 Prodrugs of protein tyrosine kinase inhibitors |
| 07/20/2006 | WO2006031715A3 Novel imidazolidin-2-one derivatives as selective androgen receptor modulators (sarms) |
| 07/20/2006 | WO2006026532A3 Methods of treatment of amyloidosis using substituted ethanolcyclicamine aspartyl protease inhibitors |
| 07/20/2006 | WO2006024018A3 Compositions for treating nociceptive pain |
| 07/20/2006 | WO2006020994A3 Compositions and methods using hyaluronic acid and hyluronidase inhibitors |
| 07/20/2006 | WO2006020277A3 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 07/20/2006 | WO2006018846A3 Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-methylene-4h- carbazol-4-one and ondansetron therefrom |
| 07/20/2006 | WO2006016903A8 1, 2,4-trioxanes and 1, 2, 4-trioxepanes |
| 07/20/2006 | WO2006015338A3 Crystalline form of donepezil hydrochloride |
| 07/20/2006 | WO2006015232A3 Use of methyl pyruvate for the purpose of increasing muscle energy production |
| 07/20/2006 | WO2006015159A3 Potassium channel inhibitors |
| 07/20/2006 | WO2006015060A3 Isoindoline compounds and methods of their use |
| 07/20/2006 | WO2006012499A3 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation |